Home/BiomeBank/Chris Hall

CH

Chris Hall

Chairman

Therapeutic Areas

Gastroenterology Immunology Metabolism Neurology Oncology Infectious Disease

BiomeBank Pipeline

Drug	Indication	Phase
BIOMICTRA®	Recurrent Clostridioides difficile infection	Marketed
BB265	Ulcerative colitis	Phase 1
FMT Capsule	Broad-spectrum gut microbiome restoration	Preclinical

Leadership Team at BiomeBank

CEO & Co‑founder

VP Clinical Translation & Co‑founder

View full BiomeBank profile